Trials / Conditions / Recurrent Vulvar Cancer

Recurrent Vulvar Cancer

9 registered clinical trials studyying Recurrent Vulvar Cancer — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulv NCT05903833	AGO Research GmbH	Phase 2
Recruiting	Electrochemotherapy for Recurrent Vulvar Cancer NCT07443475	Institute of Oncology Ljubljana	Phase 2
Terminated	Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer NCT03277482	Dana-Farber Cancer Institute	Phase 1
Completed	Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer NCT01652794	Case Comprehensive Cancer Center	Phase 1
Completed	Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer NCT01764789	Ohio State University Comprehensive Cancer Center	N/A
Completed	Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan NCT01079832	Case Comprehensive Cancer Center	Phase 2
Completed	Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Witho NCT00335998	National Cancer Institute (NCI)	Phase 1
Completed	Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074	National Cancer Institute (NCI)	Phase 1
Withdrawn	Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or NCT01313104	Northwestern University	N/A